Address |
World Trade Center Building, 15/F Tokyo Tokyo 105 Japan |
Employees | - |
Website | http://www.healios.co.jp |
Updated | 07/08/2019 |
Healios KK engages in the development and sale of ophthalmological surgery adjuvants. It aims to commercialize pharmaceutical hiPSC derived retinal pigment epithelium (RPE) cell transplantation for the treatment of age-related macular degeneration. The firm develops therapies for the regeneration of retinal function and to improve visual function in those affected with retinal degenerative diseases. |